ALPINE: A Randomized Phase 3 Study of Zanubrutinib vs. Ibrutinib for Treatment of R/R CLL and SLL

By ecancer FEATURING Jennifer Brown
By ecancer FEATURING Jennifer Brown
506 views
January 11, 2023
Comments 0
Login to view comments. Click here to Login